vTv Therapeutics
vTv Therapeutics is a North Carolina, USA-based clinical-stage pharmaceutical company, focused on the discovery and development of human therapeutics to fill unmet medical needs. The company, which was formerly known as TransTech Pharma, was listed on the Nasdaq stock exchange in 2015.
vTv has a proprietary drug discovery engine called TTP Translational Technology, and is focused on developing drug candidates for the treatment of a wide range of human diseases.
The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts.
The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.
Latest vTv Therapeutics News & Features
28 December 2023
14 April 2021
6 March 2020
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze